
Noom Med Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: people who want GLP-1 medication paired with a behavior-change app
Noom Med scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $179/4 wks ongoing
Price checked on Noom Med’s site,
What the monthly price covers
Medication
Not stated
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Noom Med adds licensed clinicians and GLP-1 prescriptions to Noom's psychology-based weight-loss app, with both compounded and brand-name options. The Microdose GLP-1Rx program starts at $79 for the first 4 weeks of medication, then $179 a month plus tax on a 12-week subscription. Brand-name plans such as Zepbound or Ozempic start at $39 plus the cost of the medication, which depends on your insurance.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Noom Med
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Noom Med at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo (microdose plan; $79 intro price)
- FDA status
- No FDA warning letter on record
How we scored Noom Med
Each dimension is scored algorithmically from Noom Med’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10Noom Med's headline is $179 a month on a microdose plan, with an intro price of $79. Compare it with other programs on the same plan basis.
Effectiveness25%
8.7/10Noom Med offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.5/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.8/10Noom Med's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.2/10Noom Med provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Noom Med review
Last checked October 2026- Confirmed current pricing across 1 dose/plan tier and 1 separate fee
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $179/mo across 1 dose/plan tier, plus a $39/mo fee that excludes the medication (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Noom Med
We walked Noom Med’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1On Noom Med's site, tap See if you're eligible.
- 2Choose a medication preference: semaglutide, tirzepatide, Wegovy pill, or open to options.
- 3The next screen asks for your sex assigned at birth, the first health question.
- Microdose and brand-plan starting prices are published on the Noom Med pages before you start the survey.
- The $79 Microdose price is a first-4-weeks offer; the ongoing price is $179 a month plus tax.
- Brand-name plans start at $39 plus the medication's own cost, which depends on your insurance.
- Standard-dose compounded GLP-1 prices are not shown before the intake.
- Subscriptions auto-renew and fees are generally non-refundable under Noom's terms.
- The site says clinician care is online and mostly asynchronous, with video visits available in some programs.
Noom Med customer support
- Phone
- (888) 266-5071
GLP-1 medications Noom Med offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Billed as a 12-week plan. Intro: 3 weeks of program plus 4 weeks of medication from $79 plus tax; then $179 a month plus tax; includes medication if prescribed.
'Starting at $39 plus any out-of-pocket cost for the medication itself'
Ready to get started?
Plans and promotions change often, so check Noom Med's current pricing and active discounts before you decide.
What we like
- Pairs GLP-1 prescriptions with Noom's psychology-based lessons, tracking tools and coaching
- Microdose program includes the medication, if prescribed, in the subscription price
- Offers compounded semaglutide and tirzepatide plus brand-name options like Zepbound and Wegovy
- Works with or without insurance, and plans are HSA/FSA eligible
- Patients can request a certificate of analysis for their compounded medication batch
- Cancel anytime before your next billing date
Watch-outs
- The $79 price covers only the first 4 weeks; the Microdose program then runs $179 a month plus tax
- Brand-name plans charge a program fee on top of the medication cost
- Subscriptions auto-renew, and fees are generally non-refundable
- Does not publish which states it serves
- Standard-dose compounded GLP-1 pricing is not shown before you sign up
- Does not name its compounding pharmacies
- Compounded medications are not FDA-approved
Noom Med: the weight-loss app that added a prescription pad
Most people already know Noom as the psychology-based diet app, the one that drills you on why you reach for the snack drawer instead of just counting the calories in it. Noom Med is the company's attempt to bolt a GLP-1 medication program onto that behavior-change curriculum. The pitch is simple: medication gets you the appetite control, and the coaching tries to make the new habits stick once you eventually taper off. If you believe the drug alone is only half the battle, this is one of the few programs built around that premise rather than treating the lessons as an afterthought.
Noom advertises its Microdose GLP-1Rx program from $79, but that's an intro price for the first 4 weeks of medication. After that, the program runs $179 a month plus tax, roughly in line with the category median of $179. What you are paying for is the bundle, the medication if prescribed plus the full Noom app and coaching, rather than a bare prescription.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 122 programs that publish one.
How the pricing works
This is where you need to read the fine print, because Noom advertises with 'starting at' language and the cost depends on which lane you pick. The Microdose program covers personalized microdose compounded semaglutide and tirzepatide, regardless of insurance, when you're prescribed. Per Noom's footnote, the intro is a 3-week subscription plus 4 weeks of medication from $79 plus tax, then $179 a month plus tax on a 12-week subscription. Noom doesn't spell out whether that 12-week term is charged monthly or upfront, so check at checkout.
There is a second lane for people who want brand-name medication such as Ozempic, Wegovy, or Zepbound. That track starts at $39, but you then owe whatever your out-of-pocket cost for the drug itself is, which depends entirely on your insurance. For an uninsured shopper, the brand route can cost far more than the program fee suggests, so treat the $39 as a program fee, not the all-in price. Medicare and Medicaid patients who want a brand-name drug can look at Klinic, which accepts both and handles the prior authorization.
- Microdose GLP-1Rx program: $79 intro for the first 4 weeks, then $179/month plus tax; medication included if prescribed, no insurance required
- Brand-name route: starts at $39, plus the drug's out-of-pocket cost, which varies by insurance
- Standard-dose compounded plans: offered, but Noom doesn't show their prices before you sign up
The medications and how you get them
The flat-rate program is built around compounded GLP-1 therapy, which uses the same active ingredients as the well-known injectables, semaglutide and tirzepatide, prepared by a compounding pharmacy rather than dispensed as a sealed brand pen. Compounded medications are not FDA-approved. Noom says it partners with USP-compliant, state-regulated pharmacies, and you can request a certificate of analysis for your batch, but it doesn't name the pharmacies. The brand-name menu is wide: Ozempic, Wegovy, the Wegovy pill, Zepbound, Mounjaro, Foundayo, and generic liraglutide.
Noom doesn't publish a dose-by-dose price ladder the way some competitors do, and it doesn't publish which states it serves. You only learn exactly what your plan looks like after you complete the intake. Build a little patience into your expectations there.
The program around the prescription
Noom's differentiator is everything wrapped around the drug. Noom pairs GLP-1 medication with its cognitive-behavioral lesson curriculum, tracking tools, and coaching. Most telehealth providers hand you a prescription and a portal; Noom hands you a structured psychology course and daily lessons alongside the clinical care, which the site describes as online and mostly asynchronous, with video visits in some programs. Plans work with or without insurance and are HSA/FSA eligible.
The coaching matters most for the GLP-1 endgame. These drugs are famous for appetite returning, and weight with it, when people stop. A program that's actively training new eating habits while you're medicated is making a bet on what happens after you taper, instead of leaving you to figure it out alone.
Who should choose it, and who should skip it
Choose Noom Med if you want the coaching, not just the prescription. Maybe you already know your eating triggers are behavioral. Maybe you've lost weight before and regained it. Or maybe you want a single program handling both the medication and the head game. In any of those cases, this is one of the stronger psychology-plus-medication bundles on the market.
Skip it if you only want the cheapest possible injection and have no interest in lessons or coaching, since app-free, medication-only providers cost less and you'd be paying for a curriculum you'll ignore. Weigh the commitment, too. Subscriptions auto-renew, you need to cancel before your next billing date, and Noom's terms say fees are generally non-refundable (California residents get a 3-business-day rescission window).
Trust, safety, and oversight
There are no FDA warning letters against Noom Med, which not every cash-pay GLP-1 operator can say. The trade-off on the transparency side is that Noom doesn't name its compounding pharmacy partners, its state coverage, or its standard-dose pricing, so some of what you're buying only becomes fully visible after intake. The prices here come straight from Noom's own site. You can see how we weigh support, pricing transparency, and safety in our scoring methodology.
The bottom line
Noom Med is the rare GLP-1 program where the wraparound support is the core of the program. After a $79 intro, $179 a month plus tax gets you microdose compounded GLP-1 access plus the behavioral lessons and coaching Noom built its name on. If you want the medication and the mindset work together, it's an easy recommendation. If you just want the shot at the lowest price, look elsewhere. And whichever lane you consider, confirm which number you're being quoted: the intro rate, the ongoing Microdose price, or a brand program fee that leaves the drug cost on you.
The Bottom Line
Noom Med scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Noom Med?
From $179 a month on a microdose plan. See current pricing and start your online intake.
Head-to-head
Compare Noom Med vs…
Noom Med scores7.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Noom Med vs Amazon One Medical
Amazon One Medical scores 8.5/10

Noom Med vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Noom Med review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Noom Med's current pricing
Plans from $179 a month on a microdose plan. Start the online intake to check eligibility and today's price.